المؤلفون: Horne S., Jenkin G., Athan E., O'Brien D.P., Buntine J., Steffen C.M., McDonald A., Deborah Friedman N., Johnson P.D.R., Callan P.P., Hughes A.

مصطلحات الفهرس: amikacin/cb [Drug Combination], drug dose reduction, fine needle aspiration biopsy, health care cost, human, hyperthermic therapy, morbidity, paradoxical drug reaction, polymerase chain reaction, practice guideline, recommended drug dose, World Health Organization, amikacin/dt [Drug Therapy], amikacin/iv [Intravenous Drug Administration], ciprofloxacin/cb [Drug Combination], ciprofloxacin/dt [Drug Therapy], ciprofloxacin/po [Oral Drug Administration], clarithromycin/cb [Drug Combination], clarithromycin/dt [Drug Therapy], clarithromycin/po [Oral Drug Administration], moxifloxacin/cb [Drug Combination], moxifloxacin/dt [Drug Therapy], moxifloxacin/po [Oral Drug Administration], prednisolone/dt [Drug Therapy], rifampicin/dt [Drug Therapy], rifampicin/po [Oral Drug Administration], streptomycin/cb [Drug Combination], streptomycin/dt [Drug Therapy], rifampicin/cb [Drug Combination], quinoline derived antiinfective agent/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], article, Australia, Buruli ulcer/dt [Drug Therapy], Buruli ulcer/pc [Prevention], Buruli ulcer/su [Surgery], Buruli ulcer/th [Therapy], clinical practice, disease transmission, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41646
Medical Journal of Australia
Click here for full text options
LibKey Link

المؤلفون: Horne S., Jenkin G., Athan E., O'Brien D.P., Buntine J., Steffen C.M., McDonald A., Deborah Friedman N., Johnson P.D.R., Callan P.P., Hughes A.

مصطلحات الفهرس: amikacin/cb [Drug Combination], drug dose reduction, fine needle aspiration biopsy, health care cost, human, hyperthermic therapy, morbidity, paradoxical drug reaction, polymerase chain reaction, practice guideline, recommended drug dose, World Health Organization, amikacin/dt [Drug Therapy], amikacin/iv [Intravenous Drug Administration], ciprofloxacin/cb [Drug Combination], ciprofloxacin/dt [Drug Therapy], ciprofloxacin/po [Oral Drug Administration], clarithromycin/cb [Drug Combination], clarithromycin/dt [Drug Therapy], clarithromycin/po [Oral Drug Administration], moxifloxacin/cb [Drug Combination], moxifloxacin/dt [Drug Therapy], moxifloxacin/po [Oral Drug Administration], prednisolone/dt [Drug Therapy], rifampicin/dt [Drug Therapy], rifampicin/po [Oral Drug Administration], streptomycin/cb [Drug Combination], streptomycin/dt [Drug Therapy], rifampicin/cb [Drug Combination], quinoline derived antiinfective agent/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], article, Australia, Buruli ulcer/dt [Drug Therapy], Buruli ulcer/pc [Prevention], Buruli ulcer/su [Surgery], Buruli ulcer/th [Therapy], clinical practice, disease transmission, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41646
Medical Journal of Australia
Click here for full text options
LibKey Link

المؤلفون: Johnson P.D.R., Quek T.Y., Fyfe J.A.M., Jenkin G.A., Buntine J.A., Athan E., Birrell M., Graham J., Lavender C.J., Hayman J.A.

مصطلحات الفهرس: hepatitis/si [Side Effect], human, hyperbaric oxygen, hyperthermic therapy, infection control, information dissemination, insect bite/pc [Prevention], kidney dysfunction/si [Side Effect], mosquito, Mycobacterium ulcerans, nonhuman, patient care, polymerase chain reaction, protective clothing, risk benefit analysis, risk reduction, skin biopsy, skin culture, skin infection/di [Diagnosis], skin infection/dt [Drug Therapy], skin infection/et [Etiology], skin infection/pc [Prevention], skin infection/su [Surgery], skin infection/th [Therapy], skin transplantation, soft tissue infection/di [Diagnosis], soft tissue infection/dt [Drug Therapy], soft tissue infection/et [Etiology], soft tissue infection/pc [Prevention], soft tissue infection/su [Surgery], soft tissue infection/th [Therapy], tendinitis/si [Side Effect], tinnitus/si [Side Effect], treatment outcome, amikacin/ae [Adverse Drug Reaction], amikacin/cb [Drug Combination], amikacin/cr [Drug Concentration], amikacin/dt [Drug Therapy], amikacin/iv [Intravenous Drug Administration], ciprofloxacin/dt [Drug Therapy], ciprofloxacin/to [Drug Toxicity], moxifloxacin/cb [Drug Combination], moxifloxacin/dt [Drug Therapy], moxifloxacin/po [Oral Drug Administration], oxygen/dt [Drug Therapy], quinoline derived antiinfective agent/ae [Adverse Drug Reaction], quinoline derived antiinfective agent/dt [Drug Therapy], rifampicin/ae [Adverse Drug Reaction], rifampicin/cb [Drug Combination], rifampicin/dt [Drug Therapy], rifampicin/po [Oral Drug Administration], streptomycin/cb [Drug Combination], streptomycin/dt [Drug Therapy], streptomycin/pa [Parenteral Drug Administration], skin care, arthropathy, article, Australia, balance disorder/si [Side Effect], Buruli ulcer/dt [Drug Therapy], Buruli ulcer/et [Etiology], Buruli ulcer/pc [Prevention], Buruli ulcer/su [Surgery], Buruli ulcer/th [Therapy], consensus development, diagnostic accuracy, diagnostic procedure, disease course, drug blood level, early diagnosis, environmental sanitation, epidemic/di [Diagnosis], epidemic/dt [Drug Therapy], epidemic/et [Etiology], epidemic/pc [Prevention], epidemic/su [Surgery], health care personnel, health care planning, hearing disorder/si [Side Effect], Article

URL: Medical Journal of Australia
Click here for full text options
LibKey Link

المؤلفون: Johnson P.D.R., Quek T.Y., Fyfe J.A.M., Jenkin G.A., Buntine J.A., Athan E., Birrell M., Graham J., Lavender C.J., Hayman J.A.

مصطلحات الفهرس: hepatitis/si [Side Effect], human, hyperbaric oxygen, hyperthermic therapy, infection control, information dissemination, insect bite/pc [Prevention], kidney dysfunction/si [Side Effect], mosquito, Mycobacterium ulcerans, nonhuman, patient care, polymerase chain reaction, protective clothing, risk benefit analysis, risk reduction, skin biopsy, skin culture, skin infection/di [Diagnosis], skin infection/dt [Drug Therapy], skin infection/et [Etiology], skin infection/pc [Prevention], skin infection/su [Surgery], skin infection/th [Therapy], skin transplantation, soft tissue infection/di [Diagnosis], soft tissue infection/dt [Drug Therapy], soft tissue infection/et [Etiology], soft tissue infection/pc [Prevention], soft tissue infection/su [Surgery], soft tissue infection/th [Therapy], tendinitis/si [Side Effect], tinnitus/si [Side Effect], treatment outcome, amikacin/ae [Adverse Drug Reaction], amikacin/cb [Drug Combination], amikacin/cr [Drug Concentration], amikacin/dt [Drug Therapy], amikacin/iv [Intravenous Drug Administration], ciprofloxacin/dt [Drug Therapy], ciprofloxacin/to [Drug Toxicity], moxifloxacin/cb [Drug Combination], moxifloxacin/dt [Drug Therapy], moxifloxacin/po [Oral Drug Administration], oxygen/dt [Drug Therapy], quinoline derived antiinfective agent/ae [Adverse Drug Reaction], quinoline derived antiinfective agent/dt [Drug Therapy], rifampicin/ae [Adverse Drug Reaction], rifampicin/cb [Drug Combination], rifampicin/dt [Drug Therapy], rifampicin/po [Oral Drug Administration], streptomycin/cb [Drug Combination], streptomycin/dt [Drug Therapy], streptomycin/pa [Parenteral Drug Administration], skin care, arthropathy, article, Australia, balance disorder/si [Side Effect], Buruli ulcer/dt [Drug Therapy], Buruli ulcer/et [Etiology], Buruli ulcer/pc [Prevention], Buruli ulcer/su [Surgery], Buruli ulcer/th [Therapy], consensus development, diagnostic accuracy, diagnostic procedure, disease course, drug blood level, early diagnosis, environmental sanitation, epidemic/di [Diagnosis], epidemic/dt [Drug Therapy], epidemic/et [Etiology], epidemic/pc [Prevention], epidemic/su [Surgery], health care personnel, health care planning, hearing disorder/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26645
Medical Journal of Australia
LibKey Link